AB 382
Revises provisions relating to health insurance coverage for biomarker testing. (BDR 57-913)
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill changes health insurance coverage for biomarker testing in Nevada. Currently, coverage is limited to biomarker tests related to cancer diagnosis, treatment, or monitoring when they are medically necessary. This bill removes that restriction, requiring public and private health plans to cover any biomarker testing supported by medical evidence, regardless of whether it's deemed medically necessary. It applies to both Medicaid and health plans for state and local employees. The bill also includes provisions to streamline the prior authorization process and clarify definitions related to biomarker testing.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.